Archive | Novo Nordisk Pharmatech A/S

Home / Archive

Novo Nordisk Pharmatech highlighting its cGMP FEF® Quats at CPhI Madrid

Tuesday 25th September 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech and Signet Chemical Corporation enter a distribution agreement for cGMP Quaternary Ammonium Compounds

Thursday 16th August 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing power of recombinant insulin human at Bioprocessing Summit Boston

Wednesday 25th July 2018

By Novo Nordisk… Learn More >

How to increase specific influenza production with recombinant human insulin

Thursday 5th July 2018

By Novo Nordisk… Learn More >

Pharmaceutical grade quaternary ammonium compounds

Monday 18th June 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing enhanced recombinant insulin advantages at Biologics Manufacturing Korea

Monday 14th May 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech brings advanced insights on recombinant insulin to BPI Europe, Amsterdam

Tuesday 17th April 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech returns to CPhI North America with latest cGMP quats

Monday 16th April 2018

By Novo Nordisk… Learn More >

Recombinant insulin for innovative biologics

Thursday 1st March 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing insulin boost to CHO cell productivity at PepTalk San Diego

Tuesday 19th December 2017

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing latest cGMP quats at CPhI Frankfurt

Wednesday 20th September 2017

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing insulin boost to cell line growth at BPI 2017 Boston

Monday 21st August 2017

By Novo Nordisk… Learn More >